Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)
Clinical trial NCT06919848 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06919848
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.